We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
+55.53%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$84.9M
AUM Growth
-$132M
(-61%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-148.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Biohaven
BHVN
|
+$41.5M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$168M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioCryst Pharmaceuticals
BCRX
$2.66B
| $44.2M | 52% |
3,846,154
| – | – |
|
|
2
Biohaven
BHVN
$2.34B
| $40.8M | 48% |
+2,936,507
| New | +$41.5M |
|
|
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $5.4K | 0.01% |
3,700
| – | – |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-1,111,111
| Closed | -$168M |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC